Sartorius Stedim Biotech (XPAR:DIM) Other Long Term Assets : €103 Mil (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Sartorius Stedim Biotech Other Long Term Assets?

Sartorius Stedim Biotech's other long-term assets for the quarter that ended in Dec. 2023 was €103 Mil.

Sartorius Stedim Biotech's quarterly other long-term assets increased from Jun. 2023 (€85 Mil) to Sep. 2023 (€96 Mil) and increased from Sep. 2023 (€96 Mil) to Dec. 2023 (€103 Mil).

Sartorius Stedim Biotech's annual other long-term assets increased from Dec. 2021 (€62 Mil) to Dec. 2022 (€89 Mil) and increased from Dec. 2022 (€89 Mil) to Dec. 2023 (€103 Mil).

Sartorius Stedim Biotech Other Long Term Assets Historical Data

The historical data trend for Sartorius Stedim Biotech's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Other Long Term Assets Chart

Sartorius Stedim Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

32.44

41.49

61.90

88.80

103.40

Sartorius Stedim Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial															88.80	89.30	84.60	95.90	103.40

Sartorius Stedim Biotech Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Sartorius Stedim Biotech (XPAR:DIM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (XPAR:DIM) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

SRTOY:USA SDMHF:USA DIM:Mexico DIMp:UK 0RG8:UK 56S1:Germany

Address

Otto-Brenner-Strasse 20, Goettingen, DEU, 37079

Website

https://www.sartorius.com

Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.